Global Metastatic Malignant Melanoma Therapy Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15121952 | Publishing Date : 27-Jan-2020 | No. of pages : 92
Detailed TOC of Global Metastatic Malignant Melanoma Therapy Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Metastatic Malignant Melanoma Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Metastatic Malignant Melanoma Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immunotherapy
1.4.3 Targeted Therapy
1.4.4 Other
1.5 Market by Application
1.5.1 Global Metastatic Malignant Melanoma Therapy Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Medical Research Organization
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Metastatic Malignant Melanoma Therapy Market Perspective (2015-2026)
2.2 Metastatic Malignant Melanoma Therapy Growth Trends by Regions
2.2.1 Metastatic Malignant Melanoma Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Metastatic Malignant Melanoma Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Metastatic Malignant Melanoma Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Metastatic Malignant Melanoma Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Metastatic Malignant Melanoma Therapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Metastatic Malignant Melanoma Therapy Players by Market Size
3.1.1 Global Top Metastatic Malignant Melanoma Therapy Players by Revenue (2015-2020)
3.1.2 Global Metastatic Malignant Melanoma Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Metastatic Malignant Melanoma Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Metastatic Malignant Melanoma Therapy Market Concentration Ratio
3.2.1 Global Metastatic Malignant Melanoma Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Metastatic Malignant Melanoma Therapy Revenue in 2019
3.3 Metastatic Malignant Melanoma Therapy Key Players Head office and Area Served
3.4 Key Players Metastatic Malignant Melanoma Therapy Product Solution and Service
3.5 Date of Enter into Metastatic Malignant Melanoma Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Metastatic Malignant Melanoma Therapy Historic Market Size by Type (2015-2020)
4.2 Global Metastatic Malignant Melanoma Therapy Forecasted Market Size by Type (2021-2026)
5 Metastatic Malignant Melanoma Therapy Breakdown Data by Application (2015-2026)
5.1 Global Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020)
5.2 Global Metastatic Malignant Melanoma Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Metastatic Malignant Melanoma Therapy Market Size (2015-2020)
6.2 Metastatic Malignant Melanoma Therapy Key Players in North America (2019-2020)
6.3 North America Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020)
6.4 North America Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Metastatic Malignant Melanoma Therapy Market Size (2015-2020)
7.2 Metastatic Malignant Melanoma Therapy Key Players in Europe (2019-2020)
7.3 Europe Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020)
7.4 Europe Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020)
8 China
8.1 China Metastatic Malignant Melanoma Therapy Market Size (2015-2020)
8.2 Metastatic Malignant Melanoma Therapy Key Players in China (2019-2020)
8.3 China Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020)
8.4 China Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Metastatic Malignant Melanoma Therapy Market Size (2015-2020)
9.2 Metastatic Malignant Melanoma Therapy Key Players in Japan (2019-2020)
9.3 Japan Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020)
9.4 Japan Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Metastatic Malignant Melanoma Therapy Market Size (2015-2020)
10.2 Metastatic Malignant Melanoma Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020)
11 India
11.1 India Metastatic Malignant Melanoma Therapy Market Size (2015-2020)
11.2 Metastatic Malignant Melanoma Therapy Key Players in India (2019-2020)
11.3 India Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020)
11.4 India Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Metastatic Malignant Melanoma Therapy Market Size (2015-2020)
12.2 Metastatic Malignant Melanoma Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020)
12.4 Central & South America Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview and Its Total Revenue
13.1.3 Merck Metastatic Malignant Melanoma Therapy Introduction
13.1.4 Merck Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview and Its Total Revenue
13.2.3 Pfizer Metastatic Malignant Melanoma Therapy Introduction
13.2.4 Pfizer Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Janssen Biotech
13.3.1 Janssen Biotech Company Details
13.3.2 Janssen Biotech Business Overview and Its Total Revenue
13.3.3 Janssen Biotech Metastatic Malignant Melanoma Therapy Introduction
13.3.4 Janssen Biotech Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
13.3.5 Janssen Biotech Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview and Its Total Revenue
13.4.3 Roche Metastatic Malignant Melanoma Therapy Introduction
13.4.4 Roche Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
13.4.5 Roche Recent Development
13.5 Navidea
13.5.1 Navidea Company Details
13.5.2 Navidea Business Overview and Its Total Revenue
13.5.3 Navidea Metastatic Malignant Melanoma Therapy Introduction
13.5.4 Navidea Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
13.5.5 Navidea Recent Development
13.6 Novartis
13.6.1 Novartis Company Details
13.6.2 Novartis Business Overview and Its Total Revenue
13.6.3 Novartis Metastatic Malignant Melanoma Therapy Introduction
13.6.4 Novartis Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
13.6.5 Novartis Recent Development
13.7 Bristol-Myers Squibb
13.7.1 Bristol-Myers Squibb Company Details
13.7.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.7.3 Bristol-Myers Squibb Metastatic Malignant Melanoma Therapy Introduction
13.7.4 Bristol-Myers Squibb Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
13.7.5 Bristol-Myers Squibb Recent Development
13.8 Enzon Pharmaceuticals
13.8.1 Enzon Pharmaceuticals Company Details
13.8.2 Enzon Pharmaceuticals Business Overview and Its Total Revenue
13.8.3 Enzon Pharmaceuticals Metastatic Malignant Melanoma Therapy Introduction
13.8.4 Enzon Pharmaceuticals Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
13.8.5 Enzon Pharmaceuticals Recent Development
13.9 Exelixis
13.9.1 Exelixis Company Details
13.9.2 Exelixis Business Overview and Its Total Revenue
13.9.3 Exelixis Metastatic Malignant Melanoma Therapy Introduction
13.9.4 Exelixis Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
13.9.5 Exelixis Recent Development
13.10 GlaxoSmithKline
13.10.1 GlaxoSmithKline Company Details
13.10.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.10.3 GlaxoSmithKline Metastatic Malignant Melanoma Therapy Introduction
13.10.4 GlaxoSmithKline Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
13.10.5 GlaxoSmithKline Recent Development
13.11 Ono Pharmaceutical
10.11.1 Ono Pharmaceutical Company Details
10.11.2 Ono Pharmaceutical Business Overview and Its Total Revenue
10.11.3 Ono Pharmaceutical Metastatic Malignant Melanoma Therapy Introduction
10.11.4 Ono Pharmaceutical Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
10.11.5 Ono Pharmaceutical Recent Development
13.12 Amgen
10.12.1 Amgen Company Details
10.12.2 Amgen Business Overview and Its Total Revenue
10.12.3 Amgen Metastatic Malignant Melanoma Therapy Introduction
10.12.4 Amgen Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
10.12.5 Amgen Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Metastatic Malignant Melanoma Therapy Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Metastatic Malignant Melanoma Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Metastatic Malignant Melanoma Therapy Revenue
Table 3. Ranking of Global Top Metastatic Malignant Melanoma Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Metastatic Malignant Melanoma Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immunotherapy
Table 6. Key Players of Targeted Therapy
Table 7. Key Players of Other
Table 8. Global Metastatic Malignant Melanoma Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Metastatic Malignant Melanoma Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Metastatic Malignant Melanoma Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Metastatic Malignant Melanoma Therapy Market Share by Regions (2015-2020)
Table 12. Global Metastatic Malignant Melanoma Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Metastatic Malignant Melanoma Therapy Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Metastatic Malignant Melanoma Therapy Market Growth Strategy
Table 18. Main Points Interviewed from Key Metastatic Malignant Melanoma Therapy Players
Table 19. Global Metastatic Malignant Melanoma Therapy Revenue by Players (2015-2020) (Million US$)
Table 20. Global Metastatic Malignant Melanoma Therapy Market Share by Players (2015-2020)
Table 21. Global Top Metastatic Malignant Melanoma Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Malignant Melanoma Therapy as of 2019)
Table 22. Global Metastatic Malignant Melanoma Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Metastatic Malignant Melanoma Therapy Product Solution and Service
Table 25. Date of Enter into Metastatic Malignant Melanoma Therapy Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$)
Table 28. Global Metastatic Malignant Melanoma Therapy Market Size Share by Type (2015-2020)
Table 29. Global Metastatic Malignant Melanoma Therapy Revenue Market Share by Type (2021-2026)
Table 30. Global Metastatic Malignant Melanoma Therapy Market Size Share by Application (2015-2020)
Table 31. Global Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$)
Table 32. Global Metastatic Malignant Melanoma Therapy Market Size Share by Application (2021-2026)
Table 33. North America Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020)
Table 35. North America Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$)
Table 36. North America Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020)
Table 37. North America Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$)
Table 38. North America Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020)
Table 39. Europe Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020)
Table 41. Europe Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020)
Table 43. Europe Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020)
Table 45. China Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$)
Table 46. China Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020)
Table 47. China Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$)
Table 48. China Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020)
Table 49. China Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$)
Table 50. China Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020)
Table 51. Japan Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020)
Table 53. Japan Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020)
Table 55. Japan Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020)
Table 59. Southeast Asia Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020)
Table 61. Southeast Asia Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020)
Table 63. India Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$)
Table 64. India Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020)
Table 65. India Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$)
Table 66. India Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020)
Table 67. India Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$)
Table 68. India Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020)
Table 71. Central & South America Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020)
Table 73. Central & South America Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020)
Table 75. Merck Company Details
Table 76. Merck Business Overview
Table 77. Merck Product
Table 78. Merck Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 79. Merck Recent Development
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Product
Table 83. Pfizer Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 84. Pfizer Recent Development
Table 85. Janssen Biotech Company Details
Table 86. Janssen Biotech Business Overview
Table 87. Janssen Biotech Product
Table 88. Janssen Biotech Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 89. Janssen Biotech Recent Development
Table 90. Roche Company Details
Table 91. Roche Business Overview
Table 92. Roche Product
Table 93. Roche Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 94. Roche Recent Development
Table 95. Navidea Company Details
Table 96. Navidea Business Overview
Table 97. Navidea Product
Table 98. Navidea Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 99. Navidea Recent Development
Table 100. Novartis Company Details
Table 101. Novartis Business Overview
Table 102. Novartis Product
Table 103. Novartis Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 104. Novartis Recent Development
Table 105. Bristol-Myers Squibb Company Details
Table 106. Bristol-Myers Squibb Business Overview
Table 107. Bristol-Myers Squibb Product
Table 108. Bristol-Myers Squibb Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 109. Bristol-Myers Squibb Recent Development
Table 110. Enzon Pharmaceuticals Business Overview
Table 111. Enzon Pharmaceuticals Product
Table 112. Enzon Pharmaceuticals Company Details
Table 113. Enzon Pharmaceuticals Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 114. Enzon Pharmaceuticals Recent Development
Table 115. Exelixis Company Details
Table 116. Exelixis Business Overview
Table 117. Exelixis Product
Table 118. Exelixis Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 119. Exelixis Recent Development
Table 120. GlaxoSmithKline Company Details
Table 121. GlaxoSmithKline Business Overview
Table 122. GlaxoSmithKline Product
Table 123. GlaxoSmithKline Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 124. GlaxoSmithKline Recent Development
Table 125. Ono Pharmaceutical Company Details
Table 126. Ono Pharmaceutical Business Overview
Table 127. Ono Pharmaceutical Product
Table 128. Ono Pharmaceutical Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 129. Ono Pharmaceutical Recent Development
Table 130. Amgen Company Details
Table 131. Amgen Business Overview
Table 132. Amgen Product
Table 133. Amgen Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 134. Amgen Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Malignant Melanoma Therapy Market Share by Type: 2020 VS 2026
Figure 2. Immunotherapy Features
Figure 3. Targeted Therapy Features
Figure 4. Other Features
Figure 5. Global Metastatic Malignant Melanoma Therapy Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Medical Research Organization Case Studies
Figure 8. Other Case Studies
Figure 9. Metastatic Malignant Melanoma Therapy Report Years Considered
Figure 10. Global Metastatic Malignant Melanoma Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Metastatic Malignant Melanoma Therapy Market Share by Regions: 2020 VS 2026
Figure 12. Global Metastatic Malignant Melanoma Therapy Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Metastatic Malignant Melanoma Therapy Market Share by Players in 2019
Figure 15. Global Top Metastatic Malignant Melanoma Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Malignant Melanoma Therapy as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Metastatic Malignant Melanoma Therapy Revenue in 2019
Figure 17. North America Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Merck Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 26. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Pfizer Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 28. Janssen Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Janssen Biotech Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 30. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Roche Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 32. Navidea Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Navidea Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 34. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Novartis Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 36. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bristol-Myers Squibb Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 38. Enzon Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Enzon Pharmaceuticals Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 40. Exelixis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Exelixis Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 42. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. GlaxoSmithKline Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 44. Ono Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Ono Pharmaceutical Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 46. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Amgen Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Keyplayers in Global Metastatic Malignant Melanoma Therapy Market Size, Status and Forecast 2020-2026
MerckPfizer
Janssen Biotech
Roche
Navidea
Novartis
Bristol-Myers Squibb
Enzon Pharmaceuticals
Exelixis
GlaxoSmithKline
Ono Pharmaceutical
Amgen